US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
イギリス
LSE
Resverlogix Corp (0VF9) 銘柄情報

Resverlogix Corp (0VF9)

1.68

0.00

(0.00%)

終了 6月19日 12:30AM

Resverlogix Corp (0VF9) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

1.68

( - )

買値

1.68

売値

1.68

出来高

0.00

0.00 日の範囲 0.00

1.68 52 週間の範囲 1.68

時価総額

前日終値

1.68

始値

-

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

$ 33,063

発行済株式数

343,841,709

配当利回り

PER

-3.34

1 株当たり利益 (EPS)

-0.02

歳入

-

純利益

-6.22M

Resverlogix Corp., a late-stage clinical biotechnology company, develops therapeutics for patients with chronic illnesses. Its lead drug is apabetalone (RVX-208), a small molecule selective bromodomain and extra-terminal inhibitor for patients with cardiovascular disease, chronic kidney disease, typ... Resverlogix Corp., a late-stage clinical biotechnology company, develops therapeutics for patients with chronic illnesses. Its lead drug is apabetalone (RVX-208), a small molecule selective bromodomain and extra-terminal inhibitor for patients with cardiovascular disease, chronic kidney disease, type 2 diabetes mellitus, low high-density lipoprotein, recent acute coronary syndrome, and post COVID-19 conditions. The company has a partnership with Eversana Life Science Services, LLC to support the commercialization of apabetalone for COVID-19 in the United States and Canada; developing cardiovascular and pulmonary arterial hypertension indications; and Medison Pharma Ltd. The company is headquartered in Calgary, Canada. 詳細を表示

セクター

-

業界

-

ウェブサイト

www.resverlogix.com

本社

Calgary, Canada

設立

-

Resverlogix Corp is listed in the sector of the ロンドン証券取引所 with ticker 0VF9. The last closing price for Resverlogix was $1.68. Over the last year, Resverlogix shares have traded in a share price range of $ 1.68 to $ 1.68.

Resverlogix currently has 343,841,709 shares in issue. The market capitalisation of Resverlogix is $577.65 million. Resverlogix has a price to earnings ratio (PE ratio) of -3.34.

Resverlogix Announces Commencement of Patient Enrollment and Dosing in a Phase 2b Trial for a Promising Canadian-Developed COVID-19 Treatment

Resverlogix Announces Commencement of Patient Enrollment and Dosing in a Phase 2b Trial for a Promising Canadian-Developed COVID-19 Treatment...

Resverlogix Enters into a Cooperation Agreement with the Supreme Council of the Arab-African Economy to Support the Development of Apabetalone for COVID-19 Patients

Resverlogix Enters into a Cooperation Agreement with the Supreme Council of the Arab-African Economy to Support the Development of Apabetalone...

Resverlogix In Active Discussions With The Kingdom of Morocco’s Ministry of Health For The Launch Of COVID-19 Clinical Studies With First-In-Class Drug Apabetalone

Resverlogix In Active Discussions With The Kingdom of Morocco’s Ministry of Health For The Launch Of COVID-19 Clinical Studies With...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	1.68	1.68	1.68	2547	1.68	DE
52	0	0	1.68	1.68	1.68	3347	1.68	DE
156	0	0	1.68	1.68	1.68	2995	1.68	DE
260	0	0	1.68	1.68	1.68	1894	1.68	DE

0VF9 - Frequently Asked Questions (FAQ)

What is the current Resverlogix Corp share price?

The current share price of Resverlogix Corp is $ 1.68

How many Resverlogix Corp shares are in issue?

Resverlogix Corp has 343,841,709 shares in issue

What is the market cap of Resverlogix Corp?

The market capitalisation of Resverlogix Corp is CAD 577.65M

What is the 1 year trading range for Resverlogix Corp share price?

Resverlogix Corp has traded in the range of $ 1.68 to $ 1.68 during the past year

What is the PE ratio of Resverlogix Corp?

The price to earnings ratio of Resverlogix Corp is -3.34

What is the registered address of Resverlogix Corp?

The registered address for Resverlogix Corp is 4820 Richard Road SW, Calgary, Alberta, T3E 6L1

What is the Resverlogix Corp website address?

The website address for Resverlogix Corp is www.resverlogix.com

Truenorth2016

Truenorth2016 4分前

Its starting to sink in, Someone understands this aint the stock you want to be on the sidelines when big news hit....Set it and forget it!!!

1plus1

YES !!!!! BRING IT ON !!!! ANOTHER 3 MIL BOUGHT

getmoreshares

getmoreshares 6分前

https://pbs.twimg.com/media/HLBHcVTWwAAOnZI?format=jpg&name=small

1plus1

WOOOOOOOOOOOOOOOOOOOO!!! SOMEONE JUST BOUGHT 6 MIL

getmoreshares

getmoreshares 6分前

https://pbs.twimg.com/media/HLBHcVTWwAAOnZI?format=jpg&name=small

BlazingStocks

BlazingStocks 7分前

$TDTH News June 18, 2026
Trident Digital Tech Holdings (Nasdaq: TDTH) Activates National RDC-PASS Digital Identity Ecosystem in the Democratic Republic of Congo Under 20-Year Public-Private Partnership

https://finance.yahoo.com/technology/articles/trident-digital-tech-holdings-

William777

William777 7分前

There's a lot more life to live!

barnyarddog

barnyarddog 7分前

https://app.rwa.xyz/treasuries

highjumper

highjumper 7分前

meitze

Not in the OTCID market. MMs control it, not the incredibly great company progress. Which makes this basic tier irrelevant and unnecessary. It's just a tool for corruption.

getmoreshares

getmoreshares 7分前

https://pbs.twimg.com/media/HLDLQGyXoAA8l4G?format=png&name=small

Myth

Nothing But The Wheel - Peter Wolf, Mick Jagger

https://www.youtube.com/watch?v=YolBtFYXVTQ

justus1

justus1 8分前

Time to pay if you want to play!

DrHigh

he has had you blocked for ages at this point.

CA Market News

CA Market News 8分前

Sekur Private Data Appoints Nathan R. Price as Special Advisor for Diplomacy & IntelligenceJune 18, 2026 11:30 AM
ACCESS NewswireAppointment strengthens Sekur as a Swiss-hosted diplomatic solution for international dialogue and negotiations

kittycattttt

kittycattttt 8分前

getmoreshares

getmoreshares 8分前

https://pbs.twimg.com/media/HLDLQGyXoAA8l4G?format=png&name=small

RIGATONI

RIGATONI 8分前

$2.60 strong volume again ~Rig

ttottip

ttottip 8分前

As it seems, today isn't our day. But this day will come soon.

corporalagarn

corporalagarn 8分前

I don't believe it is ENTA's decision to conduct these trials alone. They have been talking about partnering for these trials all along. I don't know what these trials will cost, maybe $40m - $50m? The incremental increase in royalty income is not going to cover it I don't think. My fear is nobo

Major Profits

Major Profits 9分前

Any word on the dividend or should we forget about it? 🤷

Just wondering.

TIA

GL🍀

https://i.pinimg.com/originals/42/3c/37/423c375c2e12c1a708ecc1694e472ff1.gif

europa7

europa7 9分前

European startups seek patent for privacy-preserving digital ID based on UWB, DIDs
Jun 17, 2026
https://www.biometricupdate.com/202606/european-startups-seek-patent-for-privacy-preserving-digital-id-based-on-uwb-dids

"...A pair of European companies say they have develop

shurtha2000

shurtha2000 9分前

ALDX $1.93 same story as OTLK

BadaBingPebble

BadaBingPebble 9分前

All those corrupt assholes deserve to rot in hell.

WisdomTree US Quality Gr...

Curative Biosciences (EM)

Ongold Resources

France Tourisme Immobilier

ETFS Daily Short Gold

3.400% Nts 28/06/27

SuperQ Quantum Computing

Vanguard Lifestrategy 40...

Silver One Resources

Maroc Telecom (PK)

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。